Spore.Bio is currently owned by Singular Capital Partners, through Singular Ventures II, since 2025.

When did Singular Capital Partners acquire Spore.Bio?

Singular Capital Partners acquired Spore.Bio in 2025 (active for 1 year).

Home/Companies/Healthcare/Spore.Bio

Spore.Bio

Healthcare·

France·Active·1yr hold

Spore.Bio is a healthcare company, headquartered in France.

Entry

2025

Hold

1yr

Status

Active

Est. EV

–

Investor

Singular Capital Partners

Key facts

HQFrance

SectorHealthcare

StatusActive

AI microbiology testing. Spore.Bio raised a Series A led by Singular and is listed by Singular.

See the full ownership history.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

Start free

Already a member? Sign in

More from Singular Ventures II

Other portfolio companies in the same fund.

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.

Last updated May 2026 · Sourced from public filings